Disclosures of potential conflicts of interest may be found at the end of this article. Key Words. Metastatic breast cancer x Overall survival x Record linkage x Trastuzumab Background. The evidence supporting the use of trastuzumab (T) in a metastatic setting comes from studies that included (almost) only patients who never received prior T. We investi-gated the effectiveness of T as first-line therapy for metastatic breast cancer (mBC) in women previously treated with T in the adjuvant setting. Materials and Methods. By using record linkage of five administrative health care databases of Lombardy, Italy, we identified 2,046women treatedwith T for early breast cancer (eBC) in 2006–2009, 96 of whom developed a metastasis and were retreated ...
Introduction: We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer ...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Even though randomized controlled clinical trials demonstrated improved survival by adjuvant trastuz...
Background. The evidence supporting the use of trastuzumab (T) in a metastatic setting comes from st...
Disclosure: No potential conflicts of interest were disclosed. Background. Human epidermal growth fa...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Recent studies have reported the potential clinical utility for metastatic breast cancer (MBC) patie...
BACKGROUND: Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in ad...
Item does not contain fulltextBACKGROUND: The impact of drug prescriptions in real life as opposed t...
Background: Trastuzumab targets the extracellular domain of the HER2 protein. Adding trastuzumab to ...
Background The relative efficacy of lapatinib vs. continuing trastuzumab beyond progression (TBP) in...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Background: Demetra, a multicentric observational retrospective study, was performed with the aim to...
To access publisher's full text version of this article click on the hyperlink belowTrastuzumab plus...
BACKGROUND: Patients with breast cancer are classified as having cells that over-express the human...
Introduction: We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer ...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Even though randomized controlled clinical trials demonstrated improved survival by adjuvant trastuz...
Background. The evidence supporting the use of trastuzumab (T) in a metastatic setting comes from st...
Disclosure: No potential conflicts of interest were disclosed. Background. Human epidermal growth fa...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Recent studies have reported the potential clinical utility for metastatic breast cancer (MBC) patie...
BACKGROUND: Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in ad...
Item does not contain fulltextBACKGROUND: The impact of drug prescriptions in real life as opposed t...
Background: Trastuzumab targets the extracellular domain of the HER2 protein. Adding trastuzumab to ...
Background The relative efficacy of lapatinib vs. continuing trastuzumab beyond progression (TBP) in...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Background: Demetra, a multicentric observational retrospective study, was performed with the aim to...
To access publisher's full text version of this article click on the hyperlink belowTrastuzumab plus...
BACKGROUND: Patients with breast cancer are classified as having cells that over-express the human...
Introduction: We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer ...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Even though randomized controlled clinical trials demonstrated improved survival by adjuvant trastuz...